PNPLA3 and metabolic dysfunction-associated steatotic liver disease: More prospective studies with a larger number of both sexes are necessary to analyze the impact of these genetic factors on the course of NAFLD in PLWHIV and to determine whether available treatments for NAFLD in this population provide the same benefits according to the allelic variants of PNPLA3 and MBOAT7-TMC4 in an individual patient.